Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Vycor Medical (VYCO) Short-Term Debt issuances (2017 - 2023)

Vycor Medical has reported Short-Term Debt issuances over the past 7 years, most recently at $32879.0 for Q3 2023.

  • Quarterly Short-Term Debt issuances fell 7.64% to $32879.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was -$13425.0 through Sep 2023, down 1238.48% year-over-year, with the annual reading at -$6611.0 for FY2022, 0.66% up from the prior year.
  • Short-Term Debt issuances was $32879.0 for Q3 2023 at Vycor Medical, up from -$7986.0 in the prior quarter.
  • Over five years, Short-Term Debt issuances peaked at $38727.0 in Q3 2021 and troughed at -$25003.0 in Q4 2022.
  • The 5-year median for Short-Term Debt issuances is -$8517.0 (2021), against an average of -$79.89.
  • The largest YoY upside for Short-Term Debt issuances was 116.81% in 2021 against a maximum downside of 192.66% in 2021.
  • A 5-year view of Short-Term Debt issuances shows it stood at -$23026.0 in 2019, then rose by 8.44% to -$21082.0 in 2020, then increased by 8.0% to -$19395.0 in 2021, then decreased by 28.91% to -$25003.0 in 2022, then soared by 231.5% to $32879.0 in 2023.
  • Per Business Quant, the three most recent readings for VYCO's Short-Term Debt issuances are $32879.0 (Q3 2023), -$7986.0 (Q2 2023), and -$13315.0 (Q1 2023).